StockData

Core Scientific vs IREN

CORZ and IREN side by side, both in finance services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CORZ and IREN compare

IREN grew revenue faster over the last twelve months (41.1% versus 26.4% for Core Scientific).

IREN keeps more of each dollar of sales as profit, with a net margin of −99.4% compared with −325% at Core Scientific.

IREN scores higher on the StockData Score (6 against 2 for Core Scientific), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCORZIREN
Size and price
Market cap$4.4B–
Share price$13.58$16.39
Change, 1 year−10.4%−66.3%
Change, 5 years–−13.7%
Beta (5Y)2.433.29
Employees325685
StockData Score
Total score26 (better)
Valuation score00
Growth score23 (better)
Performance score01 (better)
Health score02 (better)
Dividend score00
Valuation
P/S9.9×–
FCF yield−21.9%–
Fair value$3.49–
Margin of safety−289%–
Growth
Revenue growth (TTM)26.4%41.1% (better)
Revenue growth, 5Y average39.5%146% (better)
Net income growth (TTM)–−908%
Profitability
Gross margin28.3%68.9% (better)
Operating margin−127% (better)−148%
Net margin−325%−99.4% (better)
FCF margin−218%−127% (better)
Return on equity–−23.4%
Return on invested capital–−20.4%
Financial health
Debt / equity–1.81
Interest coverage–−17.7×
Current ratio0.893.55 (better)
Altman Z-score−1.50–
Piotroski F-score4 (better)3
Dividends and buybacks
Years of dividend growth–0
Shareholder yield0.00%–
Ownership
Held by institutions136%54.5%
Held by insiders11.7%7.9%
Insider net buying, 12 months−$6.2M–
Superinvestors holding3 (better)1
Short interest, % of float–26.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.